|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.36 USD | +1.59% |
|
-3.49% | -18.86% |
| 02/03 | Insmed Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:50 AM | |
| 24/02 | Insmed Insider Sold Shares Worth $1,615,257, According to a Recent SEC Filing | MT |
Company Valuation: Insmed Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,224 | 2,707 | 4,433 | 12,351 | 37,118 | 30,205 | - | - |
| Change | - | -16.05% | 63.79% | 178.59% | 200.52% | -18.62% | - | - |
| Enterprise Value (EV) 1 | 3,089 | 2,863 | 4,993 | 12,209 | 36,229 | 29,491 | 29,409 | 28,583 |
| Change | - | -7.33% | 74.42% | 144.52% | 196.74% | -18.6% | -0.28% | -2.81% |
| P/E ratio | -7.02x | -5.11x | -5.8x | -12.4x | -27.1x | -52.1x | 172x | 36.2x |
| PBR | 6.82x | 30.8x | -13.1x | 39.7x | 46.9x | 91x | 52.3x | 22x |
| PEG | - | -6.61x | -0.2x | -2.88x | -1.8x | 0.9x | -1x | 0x |
| Capitalization / Revenue | 17.1x | 11x | 14.5x | 34x | 61.2x | 18x | 11.1x | 7.86x |
| EV / Revenue | 16.4x | 11.7x | 16.4x | 33.6x | 59.7x | 17.5x | 10.8x | 7.44x |
| EV / EBITDA | -8.58x | -6.4x | -7.14x | -14.1x | -29.4x | -58x | 367x | 38.2x |
| EV / EBIT | -8.24x | -6.26x | -7.04x | -13.9x | -29.1x | -57.2x | 115x | 28.8x |
| EV / FCF | -8.34x | -6.98x | -9.09x | -17.3x | -37.4x | -50x | -904x | 36.1x |
| FCF Yield | -12% | -14.3% | -11% | -5.78% | -2.67% | -2% | -0.11% | 2.77% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.88 | -3.91 | -5.34 | -5.57 | -6.42 | -2.689 | 0.8167 | 3.869 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 188.5 | 245.4 | 305.2 | 363.7 | 606.4 | 1,681 | 2,725 | 3,844 |
| EBITDA 1 | -359.8 | -447 | -699 | -867.2 | -1,230 | -508.8 | 80.12 | 748.7 |
| EBIT 1 | -375.1 | -457.3 | -709.6 | -878.3 | -1,247 | -516 | 255.8 | 992.3 |
| Net income 1 | -434.7 | -481.5 | -749.6 | -913.8 | -1,277 | -573.2 | 170.9 | 896 |
| Net Debt 1 | -135.5 | 155.8 | 559.5 | -142.4 | -889.1 | -714.5 | -796.2 | -1,622 |
| Reference price 2 | 27.24 | 19.98 | 30.99 | 69.04 | 174.04 | 140.13 | 140.13 | 140.13 |
| Nbr of stocks (in thousands) | 1,18,372 | 1,35,477 | 1,43,062 | 1,78,903 | 2,13,273 | 2,15,552 | - | - |
| Announcement Date | 17/02/22 | 23/02/23 | 22/02/24 | 20/02/25 | 19/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.11x | 17.54x | -57.96x | -.--% | 3.02TCr | |
| 42.04x | 9.82x | 35.43x | 0.03% | 4.42TCr | |
| 16.01x | 5.74x | 12.63x | 1.87% | 4.05TCr | |
| -25.62x | 4.18x | -11.52x | -.--% | 2.55TCr | |
| 27.95x | 5.77x | 16.01x | -.--% | 1.92TCr | |
| 21.72x | 4.49x | 15.68x | -.--% | 1.65TCr | |
| -308.79x | 25.59x | 1408.78x | -.--% | 1.26TCr | |
| -13.36x | 5965.5x | -17.05x | -.--% | 1.17TCr | |
| -161.29x | 39.38x | -156.43x | -.--% | 1.15TCr | |
| 13.58x | 3.78x | 8.95x | -.--% | 1.08TCr | |
| Average | -43.99x | 608.18x | 125.45x | 0.19% | 2.23TCr | |
| Weighted average by Cap. | -20.63x | 324.16x | 74.07x | 0.34% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- INSM Stock
- Valuation Insmed Incorporated
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition